Press release
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leading Transformation in the Gastric Ulcers Market in 2025
Gastric Ulcers
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance, in January 2024, the Population Reference Bureau projected that the number of Americans aged 65 and older would increase by 47% from 58 million in 2022 to 82 million by 2050. This demographic shift highlights the growing importance of addressing aging-related health needs, thus driving the growth of the gastric ulcers market.
Get Your Gastric Ulcers Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report
What growth opportunities are expected to drive the gastric ulcers market's CAGR through 2034?
The gastric ulcers market has grown steadily. It is forecasted to rise from $4.29 billion in 2024 to $4.54 billion in 2025, at a CAGR of 5.9%. The growth is driven by the rising prevalence of Helicobacter pylori infections, increased use of NSAIDs, the growing elderly population, awareness campaigns for gastric ulcer prevention, and stress-related disorders.
The gastric ulcers market is projected to reach $5.64 billion by 2029, expanding at a CAGR of 5.5%. The growth is attributed to better diagnostics, unhealthy dietary habits, advanced treatments, and an aging population. Trends include combination therapies, minimally invasive treatments, digital health integration, and personalized medicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp
What are the emerging trends shaping the future of the gastric ulcers market?
Major companies in the gastric ulcer market are focused on developing new drug formulations to increase treatment efficacy and minimize side effects. New drug formulations combine various active ingredients to enhance effectiveness and patient compliance. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical manufacturer, launched Rabeprazole + Levosulpiride SR Capsules. These capsules combine a proton pump inhibitor with a prokinetic agent, providing relief for gastro-oesophageal reflux disease (GERD) and gastric ulcers by reducing acid secretion and improving gastric motility.
Which growth-oriented segments of the gastric ulcers market are leading the industry's development?
The gastric ulcers market covered in this report is segmented -
1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160
Which regions are key players in the growth of the gastric ulcers market?
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the gastric ulcers market?
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp
What Is Covered In The Gastric Ulcers Global Market Report?
•Market Size Forecast: Examine the gastric ulcers market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the gastric ulcers market for a structured understanding.
•Key Players Overview: Analyze major players in the gastric ulcers market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gastric ulcers market.
•Segment Contributions: Evaluate how different segments drive overall growth in the gastric ulcers market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gastric ulcers market.
•Industry Challenges: Identify potential risks and obstacles affecting the gastric ulcers market.
•Competitive Landscape: Review strategic developments in the gastric ulcers market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leading Transformation in the Gastric Ulcers Market in 2025 here
News-ID: 3925527 • Views: …
More Releases from The Business Research Company
Zymfentra Market Report Examines Leading Companies And Growth Opportunities
Understanding the Future Outlook of the Zymfentra Market
The Zymfentra market has been evolving steadily, driven by scientific advances and growing healthcare infrastructure. Looking ahead to 2030, the market is expected to witness considerable growth fueled by multiple factors influencing both development and patient care.
Market Size and Growth Drivers for the Zymfentra Market
During the historical period, growth was primarily propelled by improvements in recombinant enzyme technology and better diagnostic…
Zenpep Market Report Provides Insights Into Market Evolution And Growth Prospect …
The Zenpep market is gaining momentum as advancements in digestive health treatments and better disease management continue to evolve. With rising awareness and improved therapies, this sector is positioned for steady growth in the coming years. Let's explore the current market value, key factors driving expansion, leading players, and important segments shaping the future of Zenpep.
Projected Market Value and Growth Drivers for Zenpep by 2030
Historical growth in the Zenpep…
Xyntha,Xyntha Solofuse Market Report Examines Leading Companies And Growth Oppor …
The market for Xyntha and Xyntha Solofuse is poised for significant growth as advancements in hemophilia A treatment continue to evolve. With shifts toward more effective therapies and improved patient management strategies, this industry is set to witness substantial expansion in the coming years. Let's explore the current market value, the key factors driving growth, prominent players, and the main market segments shaping the landscape.
Expected Market Value of the Xyntha…
Xembify Market Report Provides Insights Into Market Evolution And Growth Prospec …
The Xembify market is gaining considerable attention due to advances in treatment options and increased awareness of immune-related disorders. This sector is evolving rapidly, driven by improvements in therapies and expanding patient access. Let's explore the current market size, key growth drivers, prominent players, and emerging trends shaping the future of Xembify.
Market Growth and Prospects for the Xembify Market
The historical expansion of the Xembify market is largely linked to…
More Releases for Pharma
Schizophrenia Market Forecast 2036: Rising Demand, Novel Therapies, and Commerci …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, Minerva Neurosciences, Karuna Therapeutics, Acadia Pharmaceuticals, Boehringer Ingelheim, Otsuka Pharmaceutical, Lyndra Therapeutics, Neurocrine Biosciences, and others.
(Albany, New York) - October 19, 2026: DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis…
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
